Is Adipose Stem Cell Therapy Covered by Insurance in Japan?

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are researching regenerative medicine in Japan, one of the first practical questions is often about money: will national health insurance, or your overseas insurer, pay for adipose-derived stem cell therapy? The short answer is that this type of treatment is generally provided as self-pay care, which means it is not covered by Japan’s public health insurance system. This article explains what that means in practice and how to prepare for a conversation with a physician at Grand Green Osaka Umekita Clinic or any other provider you are considering.

The short answer: self-pay care, not insured care

Japan’s public insurance system covers treatments that have gone through a formal approval and pricing process. Adipose-derived stem cell therapy at Grand Green Osaka Umekita Clinic is provided as a self-pay (uninsured) treatment, so the full cost is paid by the patient rather than reimbursed through the national scheme. Being self-pay does not by itself say anything about whether a treatment is suitable for you. It simply describes how the care is financed and regulated.

Because the treatment is self-pay, the clinic sets its own fees, and those fees can differ between providers. For that reason, it is best to rely on the clinic’s current fee information and on what your physician explains during a consultation, rather than on figures quoted on third-party websites or forums.

How the treatment is regulated in Japan

Self-pay does not mean unregulated. In Japan, regenerative medicine that uses a patient’s own cells is provided under the Act on the Safety of Regenerative Medicine. Under this law, a clinic submits a treatment plan that is reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare before it can offer the treatment. Cell culture and processing must also take place at facilities that meet legal requirements.

For a patient, this framework is a useful starting point for questions. You can ask which treatment plan applies to the therapy being discussed, whether it covers your condition, and how the cells are cultured and handled. A clinic that is comfortable explaining its legal basis in plain language is usually easier to evaluate than one that avoids the topic.

What the treatment involves, and why that matters for cost discussions

In adipose-derived stem cell therapy, a very small amount of fat tissue is collected from the patient under local anesthesia on an outpatient basis. Mesenchymal stem cells contained in that tissue are cultured and expanded at a specialized facility, and the cultured cells are later returned to the body by intravenous infusion. Because the cells come from the patient, this is described as an autologous approach.

Understanding these steps helps you ask better questions about what a quoted fee includes. For example, you may want to confirm whether the fat collection, the culture period, the infusion visit, follow-up appointments, and any tests are covered by one price or billed separately. The number of infusions, the timing between visits, and the overall length of the process are decisions that depend on your medical assessment, so they are best confirmed directly with your physician.

Insurance questions for overseas patients

International patients often ask whether a private or travel insurance policy from their home country might reimburse treatment received in Japan. Policies vary widely, and many exclude elective or unapproved treatments, but only your insurer can tell you how your own policy applies. If reimbursement matters to you, contact the insurer before traveling and ask in writing whether this kind of regenerative treatment is covered, and what documents they would require.

It is also wise to keep your regular doctor informed. Stem cell therapy is not a replacement for standard medical care, and decisions about existing treatments for conditions such as joint problems should be made together with the physicians who know your history. Bringing your medical records, imaging results, and a list of current medications to a consultation allows the doctor to judge more carefully whether the treatment is appropriate for you.

Questions to prepare before you contact a clinic in Osaka

A short list of questions can make a first consultation far more productive. Consider asking the following:

• Is this treatment self-pay, and what exactly does the quoted fee include?
• Which regenerative medicine treatment plan applies, and under what legal framework is it provided?
• What are the possible risks and side effects, and how are they monitored?
• What does the research say about my condition, and what remains uncertain?
• How many visits are needed, and how long should I plan to stay in Japan?
• Are there standard treatments I should continue or consider alongside this approach?

Evidence on mesenchymal stem cell therapy continues to develop, and results reported in studies do not necessarily apply to every individual. A responsible discussion should include both what has been reported and what is still unknown. Whether the treatment is suitable depends on a physician’s examination, and some people may be advised not to proceed.

Where to find more information

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is accessible from Kansai International Airport and Shin-Osaka Station. The clinic maintains an English-language information page for foreign patients, where you can review the treatment flow, fee information, risks, and frequently asked questions before reaching out. If you have further questions after reading, you can contact the clinic to arrange a consultation in a language you are comfortable with.

In summary, adipose-derived stem cell therapy in Japan is self-pay care provided under a legal framework for regenerative medicine. Costs, risks, side effects, and suitability should all be confirmed with a physician. Taking time to compare information, check your insurance position, and prepare your questions will help you make a calm and informed decision.

1. 1Self-pay careNot covered by public insurance
2. 2Legal frameworkRegenerative medicine law
3. 3Physician examSuitability and risks
4. 4Ask the clinicFees and visits

This figure is a conceptual diagram summarizing the article

References

• PMC: The global regulatory landscape of stem cell medical aesthetics: challenges, comparisons, and pathways to coordination. (2026)
• PMC: Hypoxia pretreatment enhances the therapeutic potential of mesenchymal stem cells (BMSCs) on ozone-induced lung injury in rats. (2022)
• PMC: Biomechanical Modulation of Dental Pulp Stem Cell (DPSC) Properties for Soft Tissue Engineering. (2023)
• PMC: Antibacterial Potential of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Against Clostridium Perfringens: An Experimental In Vitro and In Silico Study. (2026)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.